RecruitingPhase 1 / Phase 2NCT07020221
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Sponsor: Verastem, Inc.
Charlottesville, VA · Fairfax, VA · +11 more sites
Colorectal Cancer clinical trials in Fairfax, VA
34 recruiting colorectal cancer studies with a site in Fairfax, VA.
RecruitingPhase 1 / Phase 2NCT05786924
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Sponsor: Institut de Recherches Internationales Servier
Fairfax, VA · +20 more sites
RecruitingPhase 1NCT07094204
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Sponsor: Astellas Pharma Inc
Fairfax, VA · +10 more sites
RecruitingPhase 2NCT07023289
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Sponsor: AbbVie
Fairfax, VA · +20 more sites
RecruitingPhase 3NCT07222800
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Sponsor: Pfizer
Arlington, VA · Blacksburg, VA · Fairfax, VA · +251 more sites
RecruitingPhase 3NCT06997497
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Sponsor: Merck Sharp & Dohme LLC
Charlottesville, VA · Fairfax, VA · +46 more sites
RecruitingPhase 3NCT07228832
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Sponsor: Summit Therapeutics
Charlottesville, VA · Fairfax, VA · +110 more sites
RecruitingPhase 1NCT07454642
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Sponsor: Avacta Life Sciences Ltd
Fairfax, VA · +6 more sites
RecruitingPhase 1NCT06270706
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Sponsor: Pliant Therapeutics, Inc.
Fairfax, VA · +14 more sites
RecruitingPhase 1NCT07085091
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Sponsor: ALX Oncology Inc.
Fairfax, VA · +11 more sites
RecruitingPhase 1 / Phase 2NCT05482893
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
Sponsor: Phanes Therapeutics
Fairfax, VA · +10 more sites
RecruitingPhase 1 / Phase 2NCT06445062
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Sponsor: Revolution Medicines, Inc.
Fairfax, VA · +31 more sites
RecruitingPhase 1 / Phase 2NCT07488676
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Sponsor: Astellas Pharma Global Development, Inc.
Fairfax, VA · +17 more sites
RecruitingPhase 1 / Phase 2NCT07629960
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Sponsor: Blueprint Medicines Corporation
Fairfax, VA · +9 more sites
RecruitingPhase 1NCT07217171
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Sponsor: EvolveImmune United, Inc
Fairfax, VA · +15 more sites
RecruitingPhase 1NCT06440005
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Sponsor: Angiex, Inc.
Fairfax, VA · +6 more sites
RecruitingPhase 1NCT07321106
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Sponsor: Cartography Biosciences
Fairfax, VA · +9 more sites
RecruitingPhase 1NCT07066657
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
Sponsor: ArriVent BioPharma, Inc.
Fairfax, VA · +9 more sites
RecruitingPhase 1 / Phase 2NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Sponsor: Daiichi Sankyo
Fairfax, VA · +17 more sites
RecruitingPhase 1 / Phase 2NCT04657068
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Sponsor: Artios Pharma Ltd
Fairfax, VA · +40 more sites
RecruitingPhase 1NCT06657144
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Sponsor: Coherus Oncology, Inc.
Fairfax, VA · Norfolk, VA · +18 more sites
RecruitingPhase 1NCT07300150
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
Sponsor: PAQ Therapeutics, Inc.
Fairfax, VA · +4 more sites
RecruitingPhase 1 / Phase 2NCT07169734
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
Sponsor: Alentis Therapeutics AG
Fairfax, VA · +8 more sites
RecruitingPhase 1NCT07503808
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Sponsor: IDEAYA Biosciences
Fairfax, VA · +14 more sites
RecruitingPhase 1NCT07540572
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Sponsor: IDEAYA Biosciences
Fairfax, VA · +10 more sites
RecruitingPhase 1NCT06835569
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Sponsor: Alterome Therapeutics, Inc.
Fairfax, VA · +11 more sites
RecruitingPhase 1 / Phase 2NCT05379985
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Sponsor: Revolution Medicines, Inc.
Fairfax, VA · +20 more sites
RecruitingPhase 1NCT06720987
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
Sponsor: Kumquat Biosciences Inc.
Fairfax, VA · +10 more sites
RecruitingPhase 1 / Phase 2NCT06395519
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Sponsor: 858 Therapeutics, Inc.
Fairfax, VA · +13 more sites
RecruitingPhase 1 / Phase 2NCT06244771
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Sponsor: Frontier Medicines Corporation
Fairfax, VA · +14 more sites
RecruitingPhase 1 / Phase 2NCT07030257
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Sponsor: Tasca Therapeutics
Fairfax, VA · +12 more sites
RecruitingPhase 1NCT07317505
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
Sponsor: Conjupro Biotherapeutics, Inc.
Fairfax, VA · +2 more sites
RecruitingPhase 1NCT05856981
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Sponsor: Sairopa B.V.
Fairfax, VA · +3 more sites
RecruitingPhase 1NCT05746897
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
Sponsor: Hefei TG ImmunoPharma Co., Ltd.
Fairfax, VA · +1 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.